261 related articles for article (PubMed ID: 20956801)
1. Transferrin is a major determinant of hepcidin expression in hypotransferrinemic mice.
Bartnikas TB; Andrews NC; Fleming MD
Blood; 2011 Jan; 117(2):630-7. PubMed ID: 20956801
[TBL] [Abstract][Full Text] [Related]
2. Hemojuvelin is essential for transferrin-dependent and transferrin-independent hepcidin expression in mice.
Bartnikas TB; Fleming MD
Haematologica; 2012 Feb; 97(2):189-92. PubMed ID: 21993681
[TBL] [Abstract][Full Text] [Related]
3. The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression.
Schmidt PJ; Toran PT; Giannetti AM; Bjorkman PJ; Andrews NC
Cell Metab; 2008 Mar; 7(3):205-14. PubMed ID: 18316026
[TBL] [Abstract][Full Text] [Related]
4. Known and potential roles of transferrin in iron biology.
Bartnikas TB
Biometals; 2012 Aug; 25(4):677-86. PubMed ID: 22294463
[TBL] [Abstract][Full Text] [Related]
5. Liver iron concentrations and urinary hepcidin in beta-thalassemia.
Origa R; Galanello R; Ganz T; Giagu N; Maccioni L; Faa G; Nemeth E
Haematologica; 2007 May; 92(5):583-8. PubMed ID: 17488680
[TBL] [Abstract][Full Text] [Related]
6. Enhanced erythropoiesis in Hfe-KO mice indicates a role for Hfe in the modulation of erythroid iron homeostasis.
Ramos P; Guy E; Chen N; Proenca CC; Gardenghi S; Casu C; Follenzi A; Van Rooijen N; Grady RW; de Sousa M; Rivella S
Blood; 2011 Jan; 117(4):1379-89. PubMed ID: 21059897
[TBL] [Abstract][Full Text] [Related]
7. Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis.
Vokurka M; Krijt J; Sulc K; Necas E
Physiol Res; 2006; 55(6):667-674. PubMed ID: 16497104
[TBL] [Abstract][Full Text] [Related]
8. Transfusion suppresses erythropoiesis and increases hepcidin in adult patients with β-thalassemia major: a longitudinal study.
Pasricha SR; Frazer DM; Bowden DK; Anderson GJ
Blood; 2013 Jul; 122(1):124-33. PubMed ID: 23656728
[TBL] [Abstract][Full Text] [Related]
9. Stimulated erythropoiesis with secondary iron loading leads to a decrease in hepcidin despite an increase in bone morphogenetic protein 6 expression.
Frazer DM; Wilkins SJ; Darshan D; Badrick AC; McLaren GD; Anderson GJ
Br J Haematol; 2012 Jun; 157(5):615-26. PubMed ID: 22449175
[TBL] [Abstract][Full Text] [Related]
10. Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice.
Gardenghi S; Ramos P; Marongiu MF; Melchiori L; Breda L; Guy E; Muirhead K; Rao N; Roy CN; Andrews NC; Nemeth E; Follenzi A; An X; Mohandas N; Ginzburg Y; Rachmilewitz EA; Giardina PJ; Grady RW; Rivella S
J Clin Invest; 2010 Dec; 120(12):4466-77. PubMed ID: 21099112
[TBL] [Abstract][Full Text] [Related]
11. A tincture of hepcidin cures all: the potential for hepcidin therapeutics.
Bartnikas TB; Fleming MD
J Clin Invest; 2010 Dec; 120(12):4187-90. PubMed ID: 21099105
[TBL] [Abstract][Full Text] [Related]
12. Regulation of hepcidin and iron-overload disease.
Lee PL; Beutler E
Annu Rev Pathol; 2009; 4():489-515. PubMed ID: 19400694
[TBL] [Abstract][Full Text] [Related]
13. Hepcidin and disorders of iron metabolism.
Ganz T; Nemeth E
Annu Rev Med; 2011; 62():347-60. PubMed ID: 20887198
[TBL] [Abstract][Full Text] [Related]
14. Erythropoiesis-driven regulation of hepcidin in human red cell disorders is better reflected through concentrations of soluble transferrin receptor rather than growth differentiation factor 15.
Fertrin KY; Lanaro C; Franco-Penteado CF; de Albuquerque DM; de Mello MR; Pallis FR; Bezerra MA; Hatzlhofer BL; Olbina G; Saad ST; da Silva Araújo A; Westerman M; Costa FF
Am J Hematol; 2014 Apr; 89(4):385-90. PubMed ID: 24860871
[TBL] [Abstract][Full Text] [Related]
15. An update on iron physiology.
Muñoz M; Villar I; García-Erce JA
World J Gastroenterol; 2009 Oct; 15(37):4617-26. PubMed ID: 19787824
[TBL] [Abstract][Full Text] [Related]
16. BMPER protein is a negative regulator of hepcidin and is up-regulated in hypotransferrinemic mice.
Patel N; Masaratana P; Diaz-Castro J; Latunde-Dada GO; Qureshi A; Lockyer P; Jacob M; Arno M; Matak P; Mitry RR; Hughes RD; Dhawan A; Patterson C; Simpson RJ; McKie AT
J Biol Chem; 2012 Feb; 287(6):4099-106. PubMed ID: 22144676
[TBL] [Abstract][Full Text] [Related]
17. The molecular basis of iron overload disorders and iron-linked anemias.
Kaplan J; Ward DM; De Domenico I
Int J Hematol; 2011 Jan; 93(1):14-20. PubMed ID: 21210258
[TBL] [Abstract][Full Text] [Related]
18. Rheumatoid anemia.
Masson C
Joint Bone Spine; 2011 Mar; 78(2):131-7. PubMed ID: 20851655
[TBL] [Abstract][Full Text] [Related]
19. Decreasing TfR1 expression reverses anemia and hepcidin suppression in β-thalassemic mice.
Li H; Choesang T; Bao W; Chen H; Feola M; Garcia-Santos D; Li J; Sun S; Follenzi A; Pham P; Liu J; Zhang J; Ponka P; An X; Mohandas N; Fleming RE; Rivella S; Li G; Ginzburg YZ
Blood; 2017 Mar; 129(11):1514-1526. PubMed ID: 28151426
[TBL] [Abstract][Full Text] [Related]
20. Anemia, ineffective erythropoiesis, and hepcidin: interacting factors in abnormal iron metabolism leading to iron overload in β-thalassemia.
Gardenghi S; Grady RW; Rivella S
Hematol Oncol Clin North Am; 2010 Dec; 24(6):1089-107. PubMed ID: 21075282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
